FDA officials raise concerns with immunotherapy overuse for early-stage cancer patients: #AACR24
SAN DIEGO — As immunotherapies become more widely used before and after cancer surgery, the FDA is worried that some patients may be receiving the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
